Dr. Freda Miller, FRSC is a developmental neurobiologist at the Hospital for Sick Children Research Institute and a professor at the University of Toronto. Dr. Miller holds a Canada Research Chair in developmental neurobiology and her work focuses on development and regeneration of neurons.

Education and early life

Dr. Miller spent some of her early years in Calgary and attended the gifted program at Queen Elizabeth High School in Calgary. She received a Ph.D. degree in medical sciences at the University of Calgary and earned her B.Sc. degree in biochemistry at the University of Saskatchewan.

Freda Miller

In 2002, Miller was a founder of the Canadian biotech company Aegera Therapeutics.

Freda Miller

Achievements

Fellow, Royal Society of Canada

International Research Scholar, Howard Hughes Medical Institute

Fellow, American Association for the Advancement of Science

President of the Canadian Association for Neuroscience 2016-2017

Honors and distinctions

In recognition of Dr. Freda Miller's scientific career, trustees of the Calgary Board of Education named a new elementary school "Dr. Freda Miller School". The school opened in September 2020.

Freda Miller

Research

Dr. Freda Miller works on neuronal repair mechanism and has published over 140 articles on different areas of the nervous system, including skin stem cells, neuronal growth, survival and death. Miller also has 15 issued and pending patents.

Her research interests include:

Neural stem cells

Neurotrophin growth, connectivity and cell survival

Molecular regulation of neurogenesis

References

Year of birth missing (living people) Living people Academic staff of the University of Toronto University of Calgary alumni University of Saskatchewan alumni Fellows of the Royal Society of Canada Canadian neuroscientists